Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

20.30
+0.23001.15%
Post-market: 20.440.1400+0.69%19:53 EDT
Volume:2.81M
Turnover:56.91M
Market Cap:6.48B
PE:42.22
High:20.54
Open:20.19
Low:20.00
Close:20.07
52wk High:21.18
52wk Low:9.56
Shares:319.00M
Float Shares:191.00M
Volume Ratio:0.84
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:196.09
PE(LYR):92.27

Loading ...

Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says

MT Newswires Live
·
Sep 24

Oppenheimer Initiates Amneal Pharmaceuticals at Outperform With $27 Price Target

MT Newswires Live
·
Sep 23

US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals

Reuters
·
Sep 23

Update: Amneal Pharmaceuticals Shares Rise After FDA Approval for Lanreotide Injection

MT Newswires Live
·
Sep 22

Top Midday Gainers

MT Newswires Live
·
Sep 22

Amneal Pharmaceuticals up over 11%, on Track for Highest Close Since October 2018

Dow Jones
·
Sep 22

Europe's STOXX 600 Rallies on Tech, Banks Strength as Oil Prices Retreat

Reuters
·
Sep 22

Ipsen Shares Fall After Early Launch of U.S. Generic Rival

Dow Jones
·
Sep 21

Ipsen Falls After US FDA Approves Generic Somatuline

Reuters
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Gets FDA Approval for Generic Hormone Drug

Dow Jones
·
Sep 19

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Amneal Pharma - FDA Approves Amneal's Lanreotide Injection, 120 Mg/0.5 Ml in a Sterile, Single-Dose Prefilled Syringe

THOMSON REUTERS
·
Sep 19

Amneal Announces FDA Approval and Launch of Lanreotide Injection

THOMSON REUTERS
·
Sep 19

Amneal Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Sep 17

Leerink Partners Remains a Buy on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 17

Amneal Pharmaceuticals price target raised to $20 from $16 at Barclays

TIPRANKS
·
Sep 17

Amneal Pharmaceuticals Price Target Announced at $23.00/Share by Leerink Partners

Dow Jones
·
Sep 09

Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target

MT Newswires Live
·
Sep 09

Amneal Pharmaceuticals initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09